Published in Thromb Res on September 15, 1999
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest (2001) 2.45
Vitamin B12 and health. Can Fam Physician (2008) 1.44
A cross-sectional study to detect the prevalence of hyperhomocysteinemia in cases of deep vein thrombosis. Indian J Surg (2010) 0.83
Folic acid supplementation improves vascular function in professional dancers with endothelial dysfunction. PM R (2011) 0.79
Possible relationship of folic Acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women. J Sports Sci Med (2009) 0.76
Study on relationships among deep vein thrombosis, homocysteine & related B group vitamins. Pak J Med Sci (2015) 0.76
Association between Stable Coronary Artery Disease and In Vivo Thrombin Generation. Cardiol Res Pract (2016) 0.75
Evaluation of the effect of high-dose folic acid on endothelial dysfunction in pre-eclamptic patients: A randomized clinical trial. J Res Med Sci (2016) 0.75
Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med (1999) 2.93
Headache rate and cost of care following lumbar puncture at a single tertiary care hospital. Neurology (2011) 2.40
Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (2013) 2.35
Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J (1975) 2.29
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest (1998) 2.13
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol (1977) 1.88
Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax (2004) 1.80
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost (2006) 1.61
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61
Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet (1979) 1.57
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood (2001) 1.54
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53
Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax (2007) 1.48
Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet (1997) 1.43
Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats. Proc Natl Acad Sci U S A (2000) 1.42
Inhibition of thrombin generation by aspirin. Thromb Haemost (1994) 1.40
Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J (2000) 1.29
Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A (1997) 1.25
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol (2001) 1.25
Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. J Allergy Clin Immunol (1976) 1.25
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med (1998) 1.24
Asthma relieved by aspirin and by other cyclo-oxygenase inhibitors. Thorax (1978) 1.24
Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. J Am Coll Cardiol (1999) 1.22
Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol (2000) 1.22
Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J (2000) 1.13
Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol (2001) 1.13
Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J (1993) 1.13
The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol (1987) 1.12
Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy (2003) 1.11
Haemodynamic changes induced by prostacyclin in man. Br Heart J (1980) 1.11
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost (2006) 1.10
Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy (2009) 1.08
Oxytocin is a cardiovascular hormone. Braz J Med Biol Res (2000) 1.08
Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia. Am J Med Genet (2001) 1.05
Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med (1994) 1.05
Biochemical characterization of recombinant factor IX. Semin Hematol (1998) 1.03
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol (1998) 1.03
The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2. Oncogene (1993) 1.01
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01
The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (1996) 1.00
Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy (1997) 1.00
Oxytocin revisited: its role in cardiovascular regulation. J Neuroendocrinol (2012) 1.00
Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation (2001) 1.00
Protein kinase C activators induce membrane retrieval of type II Na+-phosphate cotransporters expressed in Xenopus oocytes. J Physiol (1999) 0.98
Bronchodilatory properties of 2-decarboxy-2-hydroxymethyl prostaglandin E1. Prostaglandins (1985) 0.98
Prostacyclin for pulmonary hypertension. Lancet (1980) 0.98
Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart (2000) 0.96
Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int Arch Allergy Immunol (1997) 0.94
Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol Res Commun (1978) 0.94
Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. N Engl J Med (2001) 0.93
Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost (1985) 0.92
Cardiopulmonary function in 1 -antitrypsin heterozygotes exposed to severe air pollution. Am Rev Respir Dis (1973) 0.92
Value of transthoracic echocardiography for the detection of high-grade coronary artery stenosis: prospective evaluation in 50 consecutive patients scheduled for coronary angiography. J Am Soc Echocardiogr (2000) 0.92
Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2000) 0.92
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg (1999) 0.92
Predictors of respiratory function deterioration after transfer of critically ill patients. Intensive Care Med (1998) 0.91
Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. Prostaglandins (1986) 0.90
Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol (1997) 0.90
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis (2002) 0.90
Heterogeneity of serum gamma-glutamyl transpeptidase in hepatobiliary diseases. Clin Chim Acta (1967) 0.90
A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma. Clin Exp Allergy (2000) 0.89
Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet (1999) 0.89
An improved manufacturing process for Xyntha/ReFacto AF. Haemophilia (2009) 0.89
Serum peptidases in myocardial infarction. Br Heart J (1972) 0.88
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy (2009) 0.88
CHO DUKX cell lineages preadapted to growth in serum-free suspension culture enable rapid development of cell culture processes for the manufacture of recombinant proteins. Biotechnol Bioeng (1996) 0.87
Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J (2003) 0.86
Sensitive enzyme immunoassay for the rapid diagnosis of influenza A virus infections in clinical specimens. Res Virol (1990) 0.86
Anti-platelet action of intravenous infusion of prostacyclin in man. Thromb Res (1978) 0.86
Myocardial infarction in status asthmaticus. Lancet (1977) 0.86
The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels. Allergy (2006) 0.86
Immunological status of patients with recurrent chest infections. Lung (1978) 0.86
Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery (1980) 0.86
Blood fibrinolytic activity, social class and habitual physical activity--II. A study of black and white men in Southern Georgia. J Chronic Dis (1980) 0.85
[Liver cirrhosis and dysimmunoglobulinemia in a patient with Pi M phenotype alpha 1-antitrypsin deficiency]. Pol Arch Med Wewn (1977) 0.85
Thromboxane generation and platelet aggregation in survivals of myocardial infarction. Thromb Haemost (1978) 0.85
Impaired response of the forearm resistance but not conductance vessels to reactive hyperemia in hypertrophic cardiomyopathy. Angiology (1999) 0.84
Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. Pharmacol Res Commun (1977) 0.84
Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns. Drugs (1983) 0.84
Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb Haemost (1986) 0.84
Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Prostaglandins (1981) 0.84
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy (2004) 0.84
Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. J Physiol Pharmacol (2007) 0.84
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart Vessels (1996) 0.84
Inhibition of prostacyclin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis. Mater Med Pol (1979) 0.83
Prostacyclin for acute coronary insufficiency. Artery (1980) 0.83
Trypsin-like activity of serum: its origin and electrophoretic separation. Clin Chim Acta (1969) 0.83
Regulation of the natriuretic peptide system in rat uterus during the estrous cycle. J Endocrinol (1997) 0.82
Hormonal regulation of natriuretic peptide system during induced ovarian follicular development in the rat. Biol Reprod (1999) 0.82
Asthma improved by aspirin-like drugs. Br J Dis Chest (1983) 0.82
Cannabidiol-induced lymphopenia does not involve NKT and NK cells. J Physiol Pharmacol (2009) 0.82
Antithrombotic actions of statins. Med Sci Monit (2001) 0.82
Aspirin and asthma. Eur J Respir Dis (1982) 0.82
[Late enzymatic test in myocardial infarction]. Pol Tyg Lek (1968) 0.81
Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk (1998) 0.81